UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000012215
Receipt number R000014283
Scientific Title A phase II study of Cisplatin+Pemetrexed +Bevacizumab for gefitinib refractory NSCLC patients with mutated EGFR
Date of disclosure of the study information 2013/11/05
Last modified on 2023/05/22 11:43:26

No. Disposal Last modified on Item of update
1 Insert 2013/11/05 11:48:04
2 Update 2014/05/21 13:57:50 Email
Email
Name of person sending information
Name of person sending information
Organization
Organization
Address
Address
Email
3 Update 2015/05/29 14:02:33 Division name
Division name
4 Update 2016/05/09 10:07:14 Name of person sending information
Name of person sending information
Division name
TEL
Email
Name of primary person or sponsor
Organization
5 Update 2018/06/14 10:46:53 Name of person sending information
Name of person sending information
TEL
Email
6 Update 2023/05/22 11:43:26 Recruitment status
Date of IRB